According to Novocure 's latest financial reports the company's current EPS (TTM) is -$1.86. In 2022 the company made an earnings per share (EPS) of -$0.88 a decrease over its 2021 EPS that were of -$0.56.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.86 | 111.36% |
2022 | -$0.88 | 57.14% |
2021 | -$0.56 | -380% |
2020 | $0.20 | -350% |
2019 | -$0.08000 | -88.57% |
2018 | -$0.70 | 0% |
2017 | -$0.70 | -54.84% |
2016 | -$1.55 | 11.87% |
2015 | -$1.39 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$2.06 | 10.75% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$6.20 | 233.33% | ๐ฌ๐ง UK |
Novavax NVAX | -$7.19 | 286.56% | ๐บ๐ธ USA |
Novocure
NVCR | -$1.86 | 0.00% | Jersey |